The Mark E. Josephson Twenty-Ninth Annual State-of-the-Art Arrhythmia Symposium 2022 | Heart Rhythm Society

The Mark E. Josephson Twenty-Ninth Annual State-of-the-Art Arrhythmia Symposium 2022

The Mark E. Josephson Twenty-Ninth Annual State-of-the-Art Arrhythmia Symposium 2022

This is the 29th year for the State-of-the-Art Arrhythmia Symposium. Using a combination of case presentations with audience participation, didactic presentations, and question and answer sessions, our goal is to educate the participants in state-of-the-art information on invasive and non-invasive electrophysiologic and electrocardiographic tools used in the current diagnosis, evaluation, and treatment of cardiac rhythm disorders. The program is taught by members of the faculty and staff from the University of Pennsylvania Health System, Department of Electrophysiology, in addition to invited speakers from other institutions. The course is structured to meet the educational needs of electrophysiologists, cardiologists, internists, nurses, and associated professionals with an interest in the care of patients with cardiac rhythm disorders. In addition to the morning session with lectures aimed at the entire audience, there are three breakout sessions in the afternoon aimed at 1) associated professionals 2) general cardiology and 3) an advanced electrophysiology session aimed at EP fellows, electrophysiologists, and EP lab staff.

COURSE DIRECTOR

Frank Marchlinski, MD, FHRS

OBJECTIVES

After completing this activity, participants should be able to:

  • Discuss the use and value of new techniques and technologies employed for complex EP device and ablation cases.
  • Review and assess the differences in the various oral anticoagulants including appropriate use, dosing, risks, and contraindications
  • Explain ECG clues to detect patients at risk for sudden death.
  • Describe the complexities regarding arrhythmia management in patients with congenital heart disease
  • Describe the appropriate evaluation and treatment for patients presenting with syncope.
  • Apply into practice the newest information regarding evaluation and treatment of atrial arrhythmias including screening for episodes and ablation indications/techniques/endpoints
  • Identify the indications for cardiac resynchronization therapy and conduction system pacing, based on QRS morphology and duration, symptoms, functional class, ejection fraction, and type of heart disease
  • Determine when to recommend antiarrhythmic medications for patients with atrial fibrillation and flutter and how to select the most appropriate drug considering the patient’s age and comorbidities
  • Describe the indications, contraindications, and complications associated with left atrial (LA) appendage occlusion and closure
  • Use the methods, techniques, associated tools, and equipment including emerging technologies to perform catheter ablation of atrial fibrillation and flutter
  • Manage perioperative anticoagulation, including bridging when appropriate
  • Discuss the indications and methods to diagnose inherited arrhythmia syndromes and arrhythmogenic cardiomyopathies, including the roles and limitations of genetic testing and the importance and limitations of family screening

The Mark E. Josephson Twenty-Ninth Annual State-of-the-Art Arrhythmia Symposium 2022

Date and Time September 10, 2022
7:45 am - 5:00 pm
Location

Philadelphia, Pennsylvania United States of America

Topics
Ablation
Atrial Arrhythmias
Atrial Fibrillation
Clinical EP
Device Therapy
Disorders